Patents by Inventor Manuela Vecchi

Manuela Vecchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS COMPRISING GENE SIGNATURES FOR STRATIFYING BREAST CANCER PATIENTS
    Publication number: 20250101532
    Abstract: The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2? breast cancer patients.
    Type: Application
    Filed: October 2, 2024
    Publication date: March 27, 2025
    Inventors: Pier Paolo DI FIORE, Salvatore PECE, Manuela VECCHI, Stefano CONFALONIERI
  • Methods and kits comprising gene signatures for stratifying breast cancer patients
    Patent number: 12139766
    Abstract: The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2? breast cancer patients.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: November 12, 2024
    Assignees: Istituto Europeo di Oncologia S.r.l., Fondazione Istituto Firc di Oncologia Molecolare (IFOM), Universita degli Studi di Milano (University of Milan)
    Inventors: Pier Paolo Di Fiore, Salvatore Pece, Manuela Vecchi, Stefano Confalonieri
  • METHODS AND KITS COMPRISING GENE SIGNATURES FOR STRATIFYING BREAST CANCER PATIENTS
    Publication number: 20230151428
    Abstract: The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2-breast cancer patients.
    Type: Application
    Filed: July 29, 2022
    Publication date: May 18, 2023
    Inventors: Pier Paolo DI FIORE, Salvatore PECE, Manuela VECCHI, Stefano CONFALONIERI
  • Methods and kits comprising gene signatures for stratifying breast cancer patients
    Patent number: 11441191
    Abstract: The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2? breast cancer patients.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: September 13, 2022
    Assignees: Istituto Europeo di Oncologia S.r.l., Fondazione Istituto Firc di Oncologia Molecolare (IFOM), University of Milan
    Inventors: Pier Paolo Di Fiore, Salvatore Pece, Manuela Vecchi, Stefano Confalonieri
  • METHODS AND KITS COMPRISING GENE SIGNATURES FOR STRATIFYING BREAST CANCER PATIENTS
    Publication number: 20190161809
    Abstract: The present invention relates to refined prognostic clinical tools, methods, and kits for the evaluation of risk and treatment of distant recurrence in ER+/HER2? breast cancer patients.
    Type: Application
    Filed: June 19, 2017
    Publication date: May 30, 2019
    Inventors: Pier Paolo DI FIORE, Salvatore PECE, Manuela VECCHI, Stefano CONFALONIERI
  • Cancer Markers
    Publication number: 20080188405
    Abstract: The invention related to methods of diagnosis and prognosis of cancer, the methods comprising determining the level of one or more gene products. In addition, the invention relates to modulators of the gene products for use in treatment of cancer. The genes include EIA-induced genes and Numb.
    Type: Application
    Filed: September 20, 2005
    Publication date: August 7, 2008
    Inventors: Pier Paolo Di Fiore, Salvatore Pece, Ian Marc Bonapace, Francesco Nicassio, Fabrizio Bianchi, Manuela Vecchi, Stefano Confalonieri